Displaying items by tag: vaccination programme

Uganda, in partnership with the WHO and other health organisations, has launched its first-ever vaccine trial for the Sudan strain of Ebola. The trial began just days after a nurse succumbed to the virus, with additional cases confirmed among his relatives. Researchers at Makerere University and the Uganda Virus Research Institute expedited the process, ensuring compliance with ethical and regulatory standards. The candidate vaccine, donated by IAVI and funded by international partners, aims to improve pandemic preparedness. Over 2,000 doses are available, though the manufacturer remains undisclosed. Uganda has a history of Ebola outbreaks, including a deadly 2000 epidemic. Contact tracing remains essential in containing the disease. This outbreak comes amid US funding freezes following the Trump administration’s withdrawal from the WHO. The region has also faced recent outbreaks of Marburg virus in Tanzania and Rwanda. Officials hope the vaccine will be a breakthrough in combating future Ebola epidemics.

NHS officials have reported that a new Covid mutation was discovered on 18 August, the most concerning variant since Omicron first emerged. Although BA.2.86 is not classified as a variant of concern, scientists say it carries a high number of mutations, and the rollout of flu and COVID-19 vaccines has been brought forward. Vaccinations for care home residents and those who are immunocompromised will now start on 11 September, not in October. This group will be followed by inviting carers, pregnant women, social care personnel, and individuals aged 65 and above to receive booster shots. The NHS vaccinations director said that although flu and Covid hit hardest in December and January, the new variant presents a greater risk, so they want to vaccinate as many people as possible sooner.